title: MTHFR gene polymorphism as a risk factor for diabetic retinopathy in type 2 diabetic patients without serum creatinine elevation.
authors.affiliation: Department of Clinical Evaluation of Medicines and Therapeutics, Graduate School of Pharmaceutical Sciences, Osaka University, Japan.
authors.forename: Makiko
authors.initials: M
authors.lastname: Maeda
authors.forename: Isamu
authors.initials: I
authors.lastname: Yamamoto
authors.forename: Masakatsu
authors.initials: M
authors.lastname: Fukuda
authors.forename: Mari
authors.initials: M
authors.lastname: Nishida
authors.forename: Junko
authors.initials: J
authors.lastname: Fujitsu
authors.forename: Shinpei
authors.initials: S
authors.lastname: Nonen
authors.forename: Tsuyoshi
authors.initials: T
authors.lastname: Igarashi
authors.forename: Takashi
authors.initials: T
authors.lastname: Motomura
authors.forename: Makiko
authors.initials: M
authors.lastname: Inaba
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Fujio
authors.forename: Junichi
authors.initials: J
authors.lastname: Azuma
mesh_terms: D003404:Creatinine / Q000097:blood*; D003924:Diabetes Mellitus, Type 2 / Q000235:genetics*; D003930:Diabetic Retinopathy / Q000097:blood* / Q000235:genetics*; D020022:Genetic Predisposition to Disease; D006801:Humans; D042965:Methylenetetrahydrofolate Reductase (NADPH2); D000587:Oxidoreductases Acting on CH-NH Group Donors / Q000235:genetics*; D011110:Polymorphism, Genetic
chemical_list: D003404:Creatinine; D000587:Oxidoreductases Acting on CH-NH Group Donors; D042965:Methylenetetrahydrofolate Reductase (NADPH2)